Category: Medosis Newsroom

On March 26, 2025, the U.S. Food and Drug Administration (FDA) approved cabozantinib (Cabometyx) as a treatment for adults and children aged 12 and older….

In a recent regulatory decision, the European Medicines Agency (EMA) has denied approval for Eli Lilly’s experimental Alzheimer’s treatment, Donanemab…..

In a promising development for cancer care, researchers are investigating the use of virtual reality as a non-invasive, drug-free method to alleviate…….

In a groundbreaking medical advancement, scientists have discovered human retinal stem-like cells capable of regenerating damaged retinal tissue, offering….

A surge in norovirus cases, often referred to as the “winter vomiting bug,” is causing concern in the United Kingdom. Health authorities are urging the…..